000 01648 a2200517 4500
005 20250514192900.0
264 0 _c20040831
008 200408s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6601954
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHitchings, A W
245 0 0 _aPrediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb.
_h[electronic resource]
260 _bBritish journal of cancer
_cAug 2004
300 _a552-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma, Transitional Cell
_xgenetics
650 0 4 _aCell Cycle
650 0 4 _aCyclin-Dependent Kinase Inhibitor p16
_xanalysis
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm Staging
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
650 0 4 _aRetinoblastoma Protein
_xanalysis
650 0 4 _aRetrospective Studies
650 0 4 _aTumor Suppressor Protein p53
_xanalysis
650 0 4 _aUrinary Bladder Neoplasms
_xgenetics
700 1 _aKumar, M
700 1 _aJordan, S
700 1 _aNargund, V
700 1 _aMartin, J
700 1 _aBerney, D M
773 0 _tBritish journal of cancer
_gvol. 91
_gno. 3
_gp. 552-7
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6601954
_zAvailable from publisher's website
999 _c14931402
_d14931402